Tolerance to self-antigens prevents the elimination of cancer by the immune system 1 , 2 .
We used synthetic chimeric antigen receptors (CARs) to overcome immunological tolerance …

Patients with multiply relapsed or refractory chronic lymphocytic leukemia (CLL) have a
poor prognosis. Chimeric antigen receptor (CAR)–modified T cells targeting CD19 have the …

Background CCR5 is the major coreceptor for human immunodeficiency virus (HIV). We
investigated whether site-specific modification of the gene (“gene editing”) — in this case, the …

The use of extended work shifts and overtime has escalated as hospitals cope with a
shortage of registered nurses (RNs). Little is known, however, about the prevalence of these …

INTRODUCTION Most cancers are recognized and attacked by the immune system but can
progress owing to tumor-mediated immunosuppression and immune evasion mechanisms. …

Chimeric antigen receptor (CAR) T cells have demonstrated promising efficacy, particularly
in hematologic malignancies. One challenge regarding CAR T cells in solid tumors is the …

The success of adoptive T cell gene transfer for treatment of cancer and HIV is predicated on
generating a response that is both durable and safe. We report long-term results from three …

OBJECTIVE: The presence of T cells within the epithelial component of tumors, as histologic
evidence of anti-tumor immunity, has been associated with a survival advantage in multiple …

BACKGROUND. CAR T cells are a promising therapy for hematologic malignancies. B cell
maturation antigen (BCMA) is a rational target in multiple myeloma (MM). METHODS. We …

• Background To minimize the occurrence of adverse events among patients, critical care
nurses must be alert to subtle changes in patients’ conditions, perform accurate clinical …